NYRx Education & Outreach: February Updates and Key Developments
Click to Enlarge
The NYRx Education & Outreach (E&O) team has released its latest Month in Review newsletter, highlighting key updates in pharmacy services, Medicaid regulations, and public health initiatives. This edition covers significant changes, including updates to Durable Medical Equipment (DME) and Medical Supplies Procedure Codes and Coverage Guidelines, effective April 1, 2025. Additionally, updates to the NYS Medicaid DMEPOS Services Fee Schedule will impact reimbursement and billing procedures for providers.
The newsletter also provides insights into new regulations for behavioral health services, aimed at improving network adequacy and reducing wait times for mental health and substance use disorder treatment. Notably, the Drug Utilization Review Board (DURB) has recommended the addition of Wegovy as a formulary drug to prevent major adverse cardiovascular events, pending approval.
Physicians and healthcare professionals are encouraged to take advantage of NYRx’s resources, including the NYRx E&O Call Center, clinical liaisons, and online educational materials. The E&O team serves as a crucial link between managed care plans, case workers, NYS agencies, and prescribers, offering support for complex pharmacy cases.
For additional details, updates, or to request a meeting with the NYRx E&O team, visit the NYRx E&O website or contact the NYRx E&O Call Center at 1-833-967-7310 (Monday-Friday, 8:00 AM – 5:00 PM ET, excluding holidays).
